1-4 of 4
Cecilia Hillard
Close
Sort by
Journal Articles

Associations between Socioeconomic Status and Bispecific LV20.19 CAR T-Cell Therapy Outcomes

Edward Paul Hackett, Nirav N. Shah, Cecilia Hillard, Elizabeth Aughey, Rachel Cusatis, Aniko Szabo, Jennifer M Knight
Journal: Blood
Blood (2021) 138 (Supplement 1): 4084.
https://doi.org/10.1182/blood-2021-146665
Published: 2021
Journal Articles

Quality of Life, Tryptophan Metabolites, and Neurotoxicity Assessments of Patients with Relapsed or Refractory B Cell Malignancies Undergoing CAR 20/19 - T Cell Therapy

Jennifer M Knight, MDMS, Igli Arapi, MSc, Aniko Szabo, PhD, Sharon Yim, BS, Garrett Sauber, BS, Cecilia Hillard, PhD, Parameswaran Hari, MD MRCP, Nirav N. Shah, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
https://doi.org/10.1182/blood-2020-141703
Published: 2020
Journal Articles

Recipient Signaling through the Cannabinoid Type 2 Receptor Regulates IL-6 Independent Neuroinflammation during Graft Versus Host Disease

Alison Moe, PhD, Garrett Sauber, BS, Vivian Zhou, PhD, Anissa Lapitz, BS, Cecilia Hillard, PhD, William R. Drobyski, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 195.
https://doi.org/10.1182/blood-2019-122746
Published: 2019
Journal Articles

Host Interleukin 6 and Indoleamine 2,3 Dioxygenase Regulate Inflammation in the Brain during Graft Versus Host Disease

Ludovic Belle, PhD, Erin Koester, MS, Emily Hansen, PhD, Michael Lawlor, PhD, Cecilia Hillard, PhD, William R. Drobyski, MD
Journal: Blood
Blood (2016) 128 (22): 2145.
https://doi.org/10.1182/blood.V128.22.2145.2145
Published: 2016